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Abstract
Background: Patient-derived tumor xenografts in mice are widely used in cancer research and have become
important in developing personalized therapies. When these xenografts are subject to DNA sequencing, the samples
could contain various amounts of mouse DNA. It has been unclear how the mouse reads would affect data analyses.
We conducted comprehensive simulations to compare three alignment strategies at different mutation rates, read
lengths, sequencing error rates, human-mouse mixing ratios and sequenced regions. We also sequenced a
nasopharyngeal carcinoma xenograft and a cell line to test how the strategies work on real data.
Results: We found the “filtering” and “combined reference” strategies performed better than aligning reads directly
to human reference in terms of alignment and variant calling accuracies. The combined reference strategy was
particularly good at reducing false negative variants calls without significantly increasing the false positive rate. In
some scenarios the performance gain of these two special handling strategies was too small for special handling to be
cost-effective, but it was found crucial when false non-synonymous SNVs should be minimized, especially in exome
sequencing.
Conclusions: Our study systematically analyzes the effects of mouse contamination in the sequencing data of
human-in-mouse xenografts. Our findings provide information for designing data analysis pipelines for these data.
Keywords: Xenografts, Nasopharyngeal carcinoma, Contamination, High-throughput sequencing
Background
Xenotransplantation is the transplantation of living cells,
tissues or organs from one species to another. Patient-
derived tumor xenografts (PDX) in mice have been
used as an important model in cancer research, where
human cancer cells or tumor tissues are transplanted to
immunodeficient mice to study the molecular character-
istics of the tumors, identify factors involved in malig-
nant transformation, invasion and metastasis, and predict
the efficacy and toxicities of cancer chemotherapeutic
agents [1-5]. Recently, there has been a new trend of using
patient-derived tumor xenografts to develop personalized
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medicine and anticancer therapies tailored for the
patient [6]. This use of xenografts is expected to turn this
traditional research tool into large-scale clinical use.
During the expansion of a xenograft in mice, human
stromal cells are largely replaced by mouse stromal cells.
When cell samples from a xenograft are extracted for
DNA sequencing, the samples could contain various
amounts of mouse DNA. In a study of 93 xenografts for
studying human pancreatic cancer, the estimated fraction
of contaminating mouse DNA ranged from 17% to as high
as 73%, with an average of 47% [7]. Due to the high simi-
larity between the human and mouse genomes, sequenc-
ing reads originating from mouse DNA could affect the
results of various kinds of analyses. For example, if a con-
taminating mouse read is aligned to the human reference
with a mismatch, the mismatch may be wrongly treated
as a single nucleotide variant (SNV) in the cancer cells.
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Mixed DNA could also affect the analysis of copy number
variations [8,9].
In the literature, there is limited previous work that
discusses how human sequencing reads with mouse con-
tamination should be handled. Conway et al. proposed
two computational methods for classifying human and
mouse reads [10], which were tested on RNA-seq data
from human, mouse, and human-in-mouse xenografts.
These methods, collectively called Xenome, align each
read to the human and mouse references independently,
and report whether it aligns to the human reference only,
the mouse reference only, both, or neither (as well as some
ambiguous cases in the k-mer version of the method).
In another study, Valdes et al. analyzed sequences from
RNA-seq experiments that cross-aligned between the
mouse and human genomes [11]. Some sequencing cen-
ters have established pipelines for mapping sequencing
reads from xenografts to both human andmouse genomes
simultaneously and selecting the reads that map better to
the human reference [12]. An implicit assumption behind
these methods is that contaminating mouse sequences
need to be specially handled in order to have accurate
downstream analysis results. In contrast, there were also
studies that decided not to explicitly handle contami-
nating mouse data and assumed they would not signifi-
cantly affect analysis results as the estimated percentage
of mouse DNA was low [13].
Is it necessary and cost-effective to perform special
handling of human sequencing reads contaminated with
mouse data? Since special handling is not part of the
standard data processing pipelines, it may incur extra
labor cost. In addition, as to be explained below, some
special handling methods require more processing time
and/or memory space. It is not very obvious whether such
extra cost is worth paying for, due to the following two
reasons.
On the one hand, while the human and mouse genomes
are highly similar as compared to other more evolutionar-
ily distant species, at the DNA level their coding sequence
similarity is only 85% on average [14]. Even for a “short”
read with 50-100 nucleotides, it is not immediately clear
what fraction of reads originated from mouse would be
aligned to the human reference.
On the other hand, if human and mouse genomes can
indeed produce very similar reads, it is then unclear if
the benefits of special handling, such as filtering out
some mouse reads and thus reducing false calling of
SNVs, would be offset by undesirable side-effects, such
as accidental filtering of human reads that causes some
legitimate SNVs to be missed.
To answer these questions, we have carried out a com-
prehensive simulation study with sequencing reads gen-
erated from the human and mouse genomes. To take
into account various scenarios that could happen in real
settings, we have considered a large combination of values
of different simulation parameters, including:
• Rate of mutation between the reference genome
sequences and the mutated sequences we used for
generating short reads
• Rate of sequencing errors
• Length of sequencing reads
• Mixing proportion of human and mouse reads
• Sequencing reads generated from exonic regions only
or both exonic and non-exonic regions
We compared three different strategies for handling the
mixed human and mouse reads, with their effectiveness
evaluated by the resulting accuracies of both sequence
alignment and genetic variant identification. The use
of simulated data allowed us to compute the accuracy
based on the actual origin and DNA sequence of each
sequencing read.
To further test howwell the three strategies work on real
data, we performed deep sequencing of a nasopharyngeal
carcinoma (NPC) PDX implanted in nude mice and an
NPC cell line that should not have mouse contamination
as control. We then applied the three strategies on these
two sets of data and compared their results.
Methods
Three computational strategies for handling sequencing
reads with contaminated data
Direct mapping. The first strategy we considered is to
map all sequencing reads directly to the human reference
genome. There are three situations in which this strategy
would be applied. First, if the contamination rate is known
or believed to be low, or most mouse reads are unlikely to
align well to the human genome due to long read length,
one may expect the contamination has limited effects on
the data analysis and apply this strategy. Second, some
sequencing services may include a standard data process-
ing pipeline for mapping reads to the human reference,
but do not offer non-standard handling of potential mouse
reads, or not without a cost. Finally, one may be unaware
of the presence of mouse contamination in the sample
and thus does not consider any special handling of the
sequencing reads.
False positives are the major potential problem of this
strategy. Some mouse reads could be falsely aligned to the
human reference, and the differences between these reads
and the aligned regions could be wrongly interpreted as
genetic variants. Although more unlikely, false negatives
are also possible as the calling of genetic variants could
be sensitive to the portion of reads supporting each allele.
For example, in a normal sample without aneuploidy, het-
erozygous SNVs would be easier to detect if the number
of reads supporting each allele is close to half. In the rare
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but possible event that mouse reads can align to the locus
well and support one of the two alleles, the other allele
could be missed due to a reduced detection score. There
are variant callers specifically designed for tumor sam-
ples that can identify somatic variants by comparing read
counts in a tumor sample and a corresponding control.
While these callers can detect variants with reads sup-
porting each allele substantially deviating from the normal
case, they can also be affected by false positive and false
negative reads caused by mouse contamination.
Filtering. The second strategy is to filter out mouse-like
reads before mapping to the human reference, by first
aligning all sequencing reads to the mouse reference and
discarding those with a high alignment score. The remain-
ing reads are then collected and aligned to the human
reference. The resulting set of aligned reads is equivalent
to those that can be aligned to the human reference only
by Xenome, although in our approach not all reads need
to be aligned to both references in order to identify this
subset. The filtering strategy is used when one wants to
minimize the amount of mouse reads falsely aligned to
the human reference and the incorrectly identified genetic
variants thereof. For instance, it could be the strategy of
choice when one can only experimentally validate a small
number of identified genetic variants, and would thus
want to minimize false positives among them.
This strategy could wrongly filter out human reads that
are highly similar to some regions in the mouse genome,
leading to false negatives.
If the contamination rate is not high, most reads would
be aligned twice, first to the mouse genome (unsuccess-
fully) and then to the human genome. The computational
time required would therefore double that of the direct
mapping strategy. Modifications to sequence alignment
pipelines are also needed to extract the unaligned reads
after mapping to the mouse reference and remap them to
the human reference.
Mapping to combined reference. The third strategy is
to combine the human and mouse reference genomes into
an artificial genome, and align all sequencing reads to
it. This strategy mainly differs from the filtering strat-
egy in how it deals with ambiguous reads that have high
sequence similarity to both human and mouse genomes.
Whereas in the filtering strategy ambiguous reads are fil-
tered in the first step, in the combined reference strategy
each read is mapped to the most similar region in the
two genomes as long as it is the only best match in the
two genomes. The resulting set of reads cannot be directly
obtained from Xenome, because the Xenome method
does not further suggest how the reads that align to both
references should be handled, but here we also report to
which reference each of them aligns better.
This strategy is expected to give a lower false nega-
tive alignment rate than the filtering strategy, because
some ambiguous reads originated from human data can
be successfully mapped to the human reference. The false
positive rate is expected to be intermediate between the
other two strategies.
One disadvantage of this strategy is the need to
construct a large artificial genome of about 6 billion
nucleotides. The corresponding indexing structure could
take up 6G bytes of main memory, which exceeds the
capacity of computing machines that run a 32-bit operat-
ing system (with a memory limit of 4 G bytes per process).
There are also implementations of alignment tools, such
as an older version of Bowtie2 [15], that cannot handle
such a huge reference genome regardless of the operating
system on which it is run.
Simulation parameter profiles
Our comprehensive simulation study involved different
combinations of values of five simulation parameters.
Three of these parameters with binary values were first
used to construct 8 setting profiles (Table 1).
Mutation rate is the probability for any base to be altered
by an SNV or indel from the reference genome, before the
resulting mutated genome was used to generate artificial
sequencing reads. It was applied to both the human and
mouse reads we generated. The purpose of this param-
eter was to investigate how the differences between a
(human or mouse) genome and the corresponding refer-
ence genome could affect read alignment results. A high
mutation rate would increase the chance for a read gener-
ated from the human genome to be better aligned to the
mouse reference than the human reference, and vice versa.
We considered twomutation rates in our simulation study,
namely zero mutation rate for studying the ideal case, and
a high mutation rate of 1% with SNV to indel ratio of 9:1,
for studying the more difficult situations.
Read length is the number of base pairs (bp) on
each simulated sequencing read. A smaller read length
would increase the chance for a read to be aligned to a
Table 1 The different profiles of parameter settings
considered in our study
Profile Mutation rate Read length Error rate
mL.len050.eL 0 50 0.0001
mL.len050.eH 0 50 0.01
mL.len100.eL 0 100 0.0001
mL.len100.eH 0 100 0.01
mH.len050.eL 0.01 50 0.0001
mH.len050.eH 0.01 50 0.01
mH.len100.eL 0.01 100 0.0001
mH.len100.eH 0.01 100 0.01
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wrong reference or non-uniquely aligned to two loci in a
reference. Reads failing to be unambiguously aligned to a
unique location would be marked as having low alignment
quality, which would in turn affect the ability to identify
any genetic variants it contains. We considered two read
lengths in our study, namely 100 bp for typical reads based
on current standards, and 50 bp for relatively short reads.
Error rate is the probability for a base on a simulated
read to be wrongly sequenced. Both simulated mutation
and sequencing error can produce reads that are different
from the original reference sequence, but only the latter
has a corresponding reduced quality score, which can be
utilized by read alignment and variant calling algorithms.
We tried two different error rates in our study, namely a
low error rate of 0.01%, and a high error rate of 1%.
We considered all value combinations of these three
parameters to form 8 setting profiles (Table 1). The pro-
files are named systematically according to their muta-
tion rate (m: Low or High), read length (len: 50 bp or
100 bp) and error rate (e: Low or High). For example,
mH.len100.eL refers to the profile with high mutation
rate, 100 bp reads, and low error rate.
For each of the 8 profiles, we further considered the
remaining two parameters each with 2 settings, leading
to a total of 8 × 2 × 2 = 32 sets of simulated data.
The first parameter is the human-mouse read ratio. We
tried a low contamination rate of 9:1 (10% contamination),
and a high contamination rate of 1:1 (50% contamination).
The second parameter is whether reads were generated
from exonic regions only, or from both exonic and non-
exonic (including intronic and intergenic) regions. Since
the human andmouse genomes are more similar in exonic
regions, we considered the exome case to test if it would
reduce read alignment and variant calling accuracies.
Simulated data generation
We downloaded the human and mouse reference
sequences hg19 and mm10, respectively, from the
UCSC Table Browser [16,17]. For each set of parame-
ter values, we used DWGSIM (http://sourceforge.net/
apps/mediawiki/dnaa/index.php?title=Whole_Genome_
Simulation) to generate human and mouse reads from
the corresponding references according to the specified
mutation rate, read length and error rate from the speci-
fied regions (whole genomes or exomes). Exonic regions
were defined according to RefSeq [18]. The amount of
data generated was equivalent to having 60 reads covering
the involved regions on average. For the case with non-
exonic reads, in order to perform the large number of
simulation runs within a reasonable amount of time, we
focused on human chromosome 14 and mouse chromo-
some 12, which are the two most similar chromosomes in
the two genomes [19,20], to study the worst-case situa-
tion. Reads were generated from these two chromosomes,
and were allowed to be aligned to anywhere in the
genomes. We have also repeated the simulations with
reads generated from the whole genomes for two param-
eter profiles, to check how much the results would be
affected by focusing on the two chromosomes.
After generating reads from each genome, we mixed
them according to the specified human-mouse read ratio
so that the total length of the reads is equivalent to 60 fold
of the simulated regions on the human genome. This “60×
average read depth” can be considered as the amount of
data perceived by someone unaware of the mouse con-
tamination. The actual effective average read depth for the
covered human regions was 60× × 0.9 = 54× and 60× ×
0.5 = 30× for the human-mouse mixing ratios of 9:1 and
1:1, respectively.
Sequence alignment and calling of genetic variants
According to the read handling strategy, we aligned the
generated reads to one or both reference genomes. We
used the highly accurate alignment tool Bowtie2 [15] for
read alignment. In an earlier version of Bowtie2, it could
not handle the artificial combined human and mouse
genome. We therefore also used another popular tool,
BWA [21], for the combined reference strategy, to see
whether the results would be different. Since some of the
required alignment results are common for the different
strategies, we devised a scheme to maximize the reuse of
these results. The details can be found in Additional file 1.
We then identified genetic variants from alignment
results using SAMtools [22]. We considered only variants
with a Phred-scale quality score [23] of 13 or above (the
default value of samtools), which corresponds to an error
probability of 10−1.3 = 0.05012 ≈ 5%.
Evaluation metrics
The effectiveness of the three strategies was compared at
three levels. First, the alignment results were compared
to the actual origin of the reads to determine alignment
performance. Second, SNVs called according to the align-
ment results were compared to the actual generated vari-
ants, to determine variant calling performance. Finally,
the functional significance of the variants was evaluated
by the performance of calling non-synonymous variants
at genic regions. At all three levels, the performance of
the three strategies were quantified by their false discov-




TP+FN , respectively. For read alignment, TP
is the number of human reads correctly aligned to the
correct position in the human reference, FP is the num-
ber of human or mouse reads incorrectly aligned to the
human reference, and FN is the number of human reads
not aligned to the human reference. For variant calling,
TP is the number of synthesized human SNVs success-
fully identified by the calling pipeline, FP is the number
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of identified SNVs not actually synthesized, and FN is the
number of synthesized human SNVs missed by the calling
pipeline.
As a baseline for evaluating how close the performance
of the three strategies was to the best case, we also pro-
duced a set of data generated from human DNA only, and
used the direct mapping strategy to align the reads. Due
to the simulated mutations, sequencing errors and non-
unique sequences, even in this baseline case the FDR and
FNR could be non-zero.
Nasopharyngeal carcinoma sequencing data
We further tested the three strategies using DNA
sequencing data from an NPC xenograft (C15 [24]) and
an NPC cell line (C666-1 [25]). We estimated the mouse
contamination level in C15 to be 29.6%, based on the num-
ber of human and mouse leptin present as determined by
real time PCR using a standard curve.We performed deep
sequencing to produce 2.56G and 2.51G reads for C15
and C666-1, respectively, which correspond to 82.3× and
80.9× coverage of the human reference genome hg19.
As with the simulated data, we applied the three strate-
gies to align sequencing reads to the human and mouse
genomes, and identified genetic variants accordingly. We
considered the whole human and mouse genomes instead
of only human chromosome 14 and mouse chromosome
12. As the actual origin of each sequencing read and the
true set of genetic variants are not known, we focused
on comparing the numbers of aligned reads and variants
called by the three strategies. Since C666-1 should be
free of mouse contamination, the direct mapping strategy
should produce the best results. We used it as a control




The complete set of results for all 32 combinations of
parameter values is given in the Additional file 2. Here
we first use the profile mH.len100.eL to compare the
direct mapping (“Direct”), filtering (“Filtering”) and com-
bined reference (“Combined”) strategies, using the dataset
with no contamination (“No contamination”) as control,
based on Bowtie2 alignments. Afterwards we will com-
pare the results based on different setting profiles and
extend the comparison to include results based on BWA
alignments. In each of these subsequent parts of analy-
sis, we fix the values of all parameters except one, so that
any difference in the alignment and variant calling accura-
cies must be due to this parameter chosen to have varying
values.
Special handling is necessary in detecting functionally
important SNVs
Figures 1 and 2 respectively show the read alignment and
variant calling results based on the dataset with reads
generated from both exonic and non-exonic regions of
human chromosome 14 and mouse chromosome 12, and
a human-mouse mixing ratio of 1:1. In both tasks, the fil-
tering and combined reference strategies achieved lower
FDRs than direct mapping. In fact, the FDRs of these
two strategies were close to the best-case scenario with
no contamination. This performance gain came with a
price of a higher alignment FNR, especially for the com-
bined reference strategy. Interestingly, for variant calling,
the combined reference strategy actually achieved a lower
FNR, probably due to a smaller amount of mouse reads
wrongly aligned to the human reference that could con-
fuse the variant caller. Nonetheless, all these differences
in both FDR and FNR were within a small percentage,
and thus the cost-effectiveness of the two special handling
strategies was not immediately clear.
A more obvious difference between the three strategies
was revealed when their ability to call non-synonymous
SNVs was compared (Table 2). While the filtering strategy
did not identify any false non-synonymous SNVs and the
combined reference strategy identified 3, the direct map-
ping strategy identified 47 of them. These false positives
could seriously affect experimental validations and down-
stream analyses. The direct mapping strategy also missed
Figure 1 Alignment accuracy of the base case. Alignment accuracy of different strategies under the mH.len100.eL setting with 1:1 human-mouse
mixing ratio and reads generated from both exonic and non-exonic regions of human chromosome 14 and mouse chromosome 12.
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Figure 2 Variant calling accuracy of the base case. Variant calling accuracy of different strategies under the mH.len100.eL setting with 1:1
human-mouse mixing ratio and reads generated from both exonic and non-exonic regions of human chromosome 14 and mouse chromosome 12.
a lot more true non-synonymous SNVs than the com-
bined reference strategy. These results show that although
overall the alignment and variant calling accuracies of the
filtering and combined reference strategies were not sub-
stantially better than direct mapping, they could really
help in identifying the genetic variants of potential func-
tional significance.
We repeated the simulations for two parameter pro-
files but had the reads generated from the whole genomes
instead, to check if the alignment (Table S3 vs. Table S8)
and variant calling (Table S9 vs. S15) accuracies would
be affected. We also compared the variant calls when
only variants with quality score larger than 13 were con-
sidered (Table S9) and when all identified variants were
considered (Table S10). The relative FDR and FNR of the
different strategies remained almost unaffected, except
when the absolute differences were very small and were
sensitive to small fluctuations.
Direct mapping is sensitive to contamination rate, while
filtering is more affected by data volume
We then explored how the detection of genetic variants
would be affected by the contamination level. We com-
pared the results at human-mouse read ratios of 9:1 and
1:1. We also included a data set with the same ratio as
the 1:1 set, but a doubled sequencing depth of 60× from
Table 2 False non-synonymous SNVs called by the
different strategies, with reads generated from both
exonic and non-exonic regions
Strategy False positive False negative
non-synonymous SNVs non-synonymous SNVs




False non-synonymous SNVs called by the different strategies, and true
non-synonymous SNVs missed by them, under the mH.len100.eL setting with
1:1 human-mouse mixing ratio and reads generated from both exonic and
non-exonic regions of human chromosome 14 and mouse chromosome 12.
each genome, to study the effects of data volume. We call
these three data sets “54×:6×”, “30×:30×” and “60×:60×”,
respectively, to reflect the effective depths of reads from
the human and mouse genomes.
Figure 3 shows that both direct mapping and filtering
performed better with 54×:6× than 30×:30×, which is
expected as the former has a lower contamination level.
In contrast, the performance of the combined reference
strategy remained almost the same in the two cases,
showing that it was not sensitive to the contamination
level.
In terms of FDR, the filtering strategy worked best with
60×:60×, followed by 54×:6× and worst with 30×:30×.
Its performance thus appears to depend more on the
actual amount of human data present (60×, 54× and 30×,
respectively) than the contamination level. For the direct
mapping strategy, it performed the best with the 54×:6×
set, followed by 30×:30× and 60×:60×, suggesting that
this strategy is more affected by the contamination level
(human-mouse ratio 9:1, 1:1 and 1:1, respectively). It is
worth noting that even though the 60×:60× set contained
more reads than the 30×:30× set at the same contami-
nation level, the variants identified by the direct mapping
strategy had a higher FDR from the former, which suggests
that when this strategy is used, producing more reads may
not help when the contamination level is high.
Exome sequencing is muchmore affected by contamination
Next we studied the effects of contamination on exome
sequencing. Figure 4 shows that in terms of read align-
ment, the FDR of the direct mapping strategy (0.044) was
substantially higher than both filtering (0.014) and com-
bined reference (0.018). This difference is much larger
than the one when reads were generated from both exonic
and non-exonic regions (Figure 1, 0.011 for direct map-
ping vs. 0.007 for both filtering and combined reference),
indicating that a lot more exonic reads were incorrectly
aligned by the direct mapping strategy due to the higher
sequence similarity between human and mouse exons
than other genomic regions. The lower FDR of the filter-
ing strategy came with a price of a slightly higher FNR,
Tso et al. BMC Genomics 2014, 15:1172 Page 7 of 11
http://www.biomedcentral.com/1471-2164/15/1172
Figure 3 Variant calling accuracy with various human-mouse mixing ratios. Variant calling accuracy of different strategies under the
mH.len100.eL setting with various human-mouse mixing ratios and reads generated from both exonic and non-exonic regions of human
chromosome 14 and mouse chromosome 12. For the no-contamination case, only human reads of the three data sets were used.
while the FNR for the combined reference strategy was
almost the same as direct mapping.
For the task of calling genetic variants, the filtering
and combined reference strategies were again superior to
direct mapping in terms of FDR, with almost all vari-
ants they called being true positives (Figure 5). In terms
of FNR, all strategies appeared to perform poorly with
38-44% true variants being missed. However, even in the
no-contamination case the FNR was about 43%, show-
ing that these variants were intrinsically difficult to call
regardless of the contamination level.
For the task of identifying non-synonymous SNVs, the
number of false positives detected by the direct mapping
strategy was much larger than filtering and combined ref-
erence (Table 3). The absolute number is also substantially
larger than when reads were generated from both exonic
and non-exonic regions (Table 2). These results show that
for exome sequencing, special handling is necessary for
calling variants accurately.
For the combined reference strategy, Bowtie2 aligned fewer
human reads correctly but resulted inmore correctly called
variants
All the above comparisons were based on Bowtie2 align-
ments. To see how much the results depend on the
alignment method, we have also used BWA to align reads
for a subset of the settings. Here we discuss the results
based on the base case mH.len100.eL.
In terms of read alignment, the two alignment meth-
ods produced almost the same FDR and FNR for all three
strategies, except that the FNR was lower for the com-
bined reference strategy when BWA was used (Figure 6).
Surprisingly, the variant calling FNR of the combined
reference strategy was higher with BWA alignment
(Figure 7). This result suggests that there were some reads
that Bowtie2 could not align or gave a low alignment score
when the combined reference strategy was used, which
were likely reads with highly similar sequences in the
human and mouse genomes. While some of these were
legitimate human reads, there were probably also a sim-
ilar amount of mouse reads not wrongly aligned to the
human reference. The net result of simultaneously hav-
ing more false negative alignments and less false positive
alignments seemed to havemade variant calling easier and
led to the lower false negative variant calls.
For the direct mapping strategy, the variant calling
FDR was higher than the other two strategies, and the
performance difference was more prominent with BWA
alignment.
Effectiveness of filtering and combined reference is
insensitive to sequencing error rate
So far we have focused on simulation results based on
the mH.len100.eL profile. We now examine how the per-
formance of the different strategies would be affected by
the rate of sequencing error. At both low and high error
Figure 4 Alignment accuracy of exonic reads. Alignment accuracy of different strategies under the mH.len100.eL setting with 1:1 human-mouse
mixing ratio and reads generated from exonic regions only of the whole human and mouse genomes.
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Figure 5 Variant calling accuracy of exonic reads. Variant calling accuracy of different strategies under the mH.len100.eL setting with 1:1
human-mouse mixing ratio and reads generated from exonic regions only of the whole human and mouse genomes.
rates, all three strategies achieved similar FNR as the no-
contamination case, and only the direct mapping strategy
had a higher FDR (Figure 8). These results suggest that the
filtering and combined reference strategies were equally
effective in both scenarios with their results insensitive to
the tested sequencing error rates.
Special handling has a slightly greater benefit when reads are
short
Finally, we checked how the performance of the differ-
ent strategies would be affected by read length. Figure 9
shows that in general all strategies achieved better per-
formance when reads were longer, which is expected as
longer reads are easier to align correctly. The filtering and
combined reference strategies consistently performed bet-
ter than the direct mapping strategy in terms of FDR,
with a slightly larger performance difference when reads
were short. Again, there were no significant differences
between the three strategies in terms of FNR.
Nasopharyngeal carcinoma sequencing data
We then applied the three alignment strategies to our
NPC sequencing data. Table 4 shows the alignment statis-
tics. For C666-1, which is expected to contain no mouse
contamination, the filtering strategy aligned about 6 mil-
lion fewer reads to the human reference as they were
aligned to the mouse reference. Most of them should be
Table 3 False non-synonymous SNVs called by the
different strategies, with reads generated from only
exonic regions
Strategy False positive False negative
non-synonymous SNVs non-synonymous SNVs




False non-synonymous SNVs called by the different strategies, and true
non-synonymous SNVs missed by them, under the mH.len100.eL setting with
1:1 human-mouse mixing ratio and reads generated from exonic regions only of
human chromosome 14 and mouse chromosome 12.
false negatives. In comparison, the combined reference
strategy aligned only about 350 thousand reads to the
mouse reference, but had 60million more reads unaligned
to either reference as compared to the filtering strategy,
most of which likely had high similarity to some regions
in both references. Taking the number of reads aligned to
the mouse reference as a fraction of the number of reads
aligned to either reference, the estimated mouse contam-
ination rates based on the direct mapping, filtering and
combined reference strategies are 0.25%, 0.26% and 0.01%,
respectively. These low values are all consistent with the
expectation of zero contamination in the data.
For C15, when all reads were aligned to the mouse ref-
erence, about 681 million reads were successfully aligned.
This number is close to the number of reads aligned to
the mouse reference by the combined reference strategy
(about 676 million), and thus can be used to estimate the
amount of mouse contamination in the data. Again, tak-
ing it as a ratio of the total number of reads aligned to
either reference, the estimated contamination rates were
27.6%, 27.8% and 27.5% for the direct mapping, filtering
and combined reference strategies, respectively, which are
all close to the 29.6% based on our leptin RT-PCR results.
With this fairly high contamination rate, we expected spe-
cial handling strategies would be necessary according to
our simulation results above.
Indeed, when we compared the numbers of SNVs iden-
tified by the three strategies (Figure 10, left panel), we
found that while a large number of (about 3.6 million)
variants were commonly found by all three strategies (this
large number is expected due to a known homozygous
mutation in the mismatch repair gene hPMS1 in C666-
1, and the expression of high levels of the viral oncogene
LMP1 in C15, which can induce genomic instability and
increase the number of mutations [26]), there were also
a significant number identified by only some strategies.
For instance, the direct mapping strategy identified about
8,800 variants not identified by the other strategies, most
of which are believed to be false positives due to themouse
contamination. In contrast, only about 1,300 variants were
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Figure 6 Alignment accuracy based on two alignment methods. Alignment accuracy of different strategies based on two alignment methods,
under the mH.len100.eL setting with 1:1 human-mouse mixing ratio and reads generated from both exonic and non-exonic regions of human
chromosome 14 and mouse chromosome 12.
Figure 7 Variant calling accuracy based on two alignment methods. Variant calling accuracy of different strategies based on two alignment
methods, under the mH.len100.eL setting with 1:1 human-mouse mixing ratio and reads generated from both exonic and non-exonic regions of
human chromosome 14 and mouse chromosome 12.
Figure 8 Alignment accuracy at different sequencing error rates. Alignment accuracy of different strategies under the mH.len100.eL and
mH.len100.eH settings with 1:1 human-mouse mixing ratio and reads generated from both exonic and non-exonic regions of human chromosome
14 and mouse chromosome 12.
Figure 9 Alignment accuracy at different read lengths. Alignment accuracy of different strategies under the mH.len100.eL and mH.len050.eL
settings with 1:1 human-mouse mixing ratio and reads generated from both exonic and non-exonic regions of human chromosome 14 and mouse
chromosome 12.
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Table 4 Alignment statistics of the NPC data
Mapping strategy Reference Mapped reads Unmapped reads
C666-1
Direct hg19 2,399,396,153 111,814,507
mm10* 6,121,700 2,505,088,960
Filtering hg19** 2,392,763,986 111,689,642
Combined hg19 2,340,660,573 170,203,874
mm10 346,213
C15
Direct hg19 1,786,870,566 768,689,454
mm10* 681,133,817 1,874,426,203




*For comparison, we also aligned all reads to the mouse reference.
**These are the numbers of reads aligned to the human reference after
discarding those aligned to the mouse reference.
uniquely identified by the filtering strategy. Interestingly,
there were also about 3,400 variants only identified by
the combined reference strategy. In our simulation this
strategy had the lowest FNR in many settings (see Figure 2
for example), therefore we believe some of these uniquely
identified variants are legitimate variants that weremissed
by the other two strategies. Similar trends are also seen
for the non-synonymous SNVs (Figure 10, right panel),
where direct mapping detected 323 unique SNVs that are
likely false positives, and the combined-reference strategy
detected 9 potentially real SNVs missed by the other two
strategies.
Conclusions
In this paper, we have used a large number of simula-
tions to compare the performance of the direct map-
ping, filtering and combined reference strategies when
human sequencing reads are contaminated with mouse
data. We have shown that in general, the two special
handling strategies (filtering and combined reference)
performed better than the direct mapping strategy that
simply aligned all human and mouse reads to the human
reference.
We found that in terms of calling non-synonymous
SNVs, special handling methods were able to identify
much fewer false positives than direct mapping, espe-
cially when reads were generated from exons only. We
recommend that when the precision of the identified non-
synonymous SNVs is more important than coverage, spe-
cial handling should be applied. This recommendation is
supported by the large number of variants only identified
by direct mapping from C15, most of which are believed
to be false positives.
In other situations, our simulation results provide infor-
mation for evaluating the cost-effectiveness of special
handling. In particular, we have shown that there are sit-
uations in which the direct mapping strategy performed
only slightly worse than having special handling. One
may use standard read processing pipelines to save extra
bioinformatics cost in such situations.
In our simulations the combined reference strategy usu-
ally identified more true genetic variants than filtering
at about the same precision. If special handling is to be
applied, we suggest that the combined reference strategy
could be a better choice.
Overall, the best strategy to take would depend on the
particular parameter setting, project goal, sample size,
and resources available. We suggest using our simula-
tion results directly, or to perform similar simulations, to
estimate the differences in alignment and variant calling
accuracies of the different strategies. More fine-grained
analyses could also be performed, for example to inves-
tigate these performance differences when only a certain
number of the most confident variants from each strategy
are considered. These results would suggest the poten-
tial numbers of false positives and false negatives in these
Figure 10 Number of SNVs identified from C15 according to the three alignment strategies.
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top cases, which could guide the calculation of the rela-
tive computational and experimental costs when scaling
up the number of samples.
Additional files
Additional file 1: Additional material note.Minimizing sequence
alignment runs when obtaining results for all parameter setting profiles.
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